Caffeine (200 mg)
Caffeine (200 mg) is a pharmaceutical drug with 7 clinical trials. Currently 3 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
3
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity
Oral Caffeine and Spinal-Induced Hypotension
Impact of Chronic and Acute Caffeine Intake on the Hematopoietic System
Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI
Clinical Trials (7)
Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity
Oral Caffeine and Spinal-Induced Hypotension
Impact of Chronic and Acute Caffeine Intake on the Hematopoietic System
Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI
Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults
Does Caffeine Reduce Postoperative Bowel Paralysis After Elective Colectomy?
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7